1-4 of 4
Nabiul Hasan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Leukemia Initiating Cells In Acute Lymphoblastic Leukemia Are Characterized By Low Metabolic Activity and Enriched In Early Cell Cycle

Luca Trentin, PhD, Manon Queudeville, MD, Sarah M Eckhoff, MD, Manuel Herrmann, Simone Miller, Sandra Lutz, Nabiul Hasan, Klaus-Michael Debatin, MD PhD, Lueder H Meyer, MD PhD
Journal: Blood
Blood (2013) 122 (21): 4197.
https://doi.org/10.1182/blood.V122.21.4197.4197
Published: 2013
Journal Articles

CRLF2 Rearrangement Is Not Associated with Activated mTOR Pathway in NOD/SCID/huALL Xenograft Mouse Model.

Md. Nabiul Hasan, MSc, Silvia Bresolin, PhD, Ilaria Bronzini, PhD, Chiara Palmi, PhD, Manon Queudeville, MD, Sarah Mirjam Eckhoff, MD, Luca Trentin, PhD, Giovanni Cazzaniga, PhD, Geertury te Kronnie, PhD, Klaus-Michael Debatin, MD, PhD, Lüder-Hinrich Meyer, MD
Journal: Blood
Blood (2012) 120 (21): 2518.
https://doi.org/10.1182/blood.V120.21.2518.2518
Published: 2012
Journal Articles

Rapid BCP-ALL Engraftment in NOD/SCID Mice Is Characterized by a High Leukemia Initiating Cell (LIC) Frequency.

Luca Trentin, PhD, Manon Queudeville, MD, Sarah M. Eckhoff, MD, Felix Seyfried, Manuel Herrmann, Simone Miller, Nabiul Hasan, Klaus-Michael Debatin, MD, PhD, Lueder H. Meyer, MD
Journal: Blood
Blood (2012) 120 (21): 2985.
https://doi.org/10.1182/blood.V120.21.2985.2985
Published: 2012
Journal Articles

Hyperactivated mTOR Signaling Is a Characteristic Feature of High Risk Acute Lymphoblastic Leukemia and Can Be Effectively Targeted in a Preclinical NOD/SCID/huALL Xenograft Mouse Model

Md. Nabiul Hasan, MSc, Manon Queudeville, MD, Sarah Mirjam Eckhoff, MD, Manuel Herrmann, Simone Miller, Luca Trentin, PhD, Klaus-Michael Debatin, MD PhD, Lueder Hinrich Meyer, MD
Journal: Blood
Blood (2011) 118 (21): 2572.
https://doi.org/10.1182/blood.V118.21.2572.2572
Published: 2011